These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25650072)

  • 1. Differential effects of leptin and adiponectin in endothelial angiogenesis.
    Adya R; Tan BK; Randeva HS
    J Diabetes Res; 2015; 2015():648239. PubMed ID: 25650072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines as mediators of endothelial function and atherosclerosis.
    Ntaios G; Gatselis NK; Makaritsis K; Dalekos GN
    Atherosclerosis; 2013 Apr; 227(2):216-21. PubMed ID: 23332774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines in relation to cardiovascular disease.
    Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
    Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines and the cardiovascular system: mechanisms mediating health and disease.
    Northcott JM; Yeganeh A; Taylor CG; Zahradka P; Wigle JT
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1029-59. PubMed ID: 22646022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.
    Blüher M; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):131-45. PubMed ID: 25497344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review.
    Kawwass JF; Summer R; Kallen CB
    Mol Hum Reprod; 2015 Aug; 21(8):617-32. PubMed ID: 25964237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines in neurovascular diseases.
    Opatrilova R; Caprnda M; Kubatka P; Valentova V; Uramova S; Nosal V; Gaspar L; Zachar L; Mozos I; Petrovic D; Dragasek J; Filipova S; Büsselberg D; Zulli A; Rodrigo L; Kruzliak P; Krasnik V
    Biomed Pharmacother; 2018 Feb; 98():424-432. PubMed ID: 29278852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
    Kopff B; Jegier A
    Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endothelial dysfunction driven by adipocitokines in the development and progression of microvascular complications in patients with type 1 and type 2 diabetes.
    Blaslov K; Bulum T; Duvnjak L
    Med Hypotheses; 2015 Jun; 84(6):593-5. PubMed ID: 25792103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
    Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
    Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the "adipokine paradox": When the classic proatherogenic adipokine leptin is deemed the beneficial one.
    Antonopoulos AS; Antoniades C; Tousoulis D
    Int J Cardiol; 2015 Oct; 197():125-7. PubMed ID: 26126055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue, inflammation and endothelial dysfunction.
    Chudek J; Wiecek A
    Pharmacol Rep; 2006; 58 Suppl():81-8. PubMed ID: 17332676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases.
    Elbatarny HS; Netherton SJ; Ovens JD; Ferguson AV; Maurice DH
    Eur J Pharmacol; 2007 Mar; 558(1-3):7-13. PubMed ID: 17207790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokines and coronary vasomotor dysfunction.
    Knudson JD; Dick GM; Tune JD
    Exp Biol Med (Maywood); 2007 Jun; 232(6):727-36. PubMed ID: 17526764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines and endothelial dysfunction in obesity WHO°III.
    Bachmayer C; Kemmer A; Ehrmann N; Hasenberg T; Lammert A; Hammes HP
    Microvasc Res; 2013 Sep; 89():129-33. PubMed ID: 23648313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines and thrombosis.
    Schäfer K; Konstantinides S
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):864-71. PubMed ID: 21848866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels.
    Seres I; Bajnok L; Harangi M; Sztanek F; Koncsos P; Paragh G
    Adv Exp Med Biol; 2010; 660():129-42. PubMed ID: 20221876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.